Dissociation of C-Reactive Protein Levels from Long-Chain Omega-3 Fatty Acid Status and Antidepressant Response in Adolescents with Major Depressive Disorder: An Open-Label Dose-Ranging Trial

Authors

  • Robert K. McNamara Department of Psychiatry and Behavioral Neuroscience,University of Cincinnati College of Medicine,US
  • Mary Perry Inflammation Research Foundation,US
  • Barry Sears Inflammation Research Foundation

DOI:

https://doi.org/10.6000/1929-5634.2013.02.04.8

Keywords:

Major depressive disorder, C-Reactive Protein (CRP), Omega-3 Fatty Acids, Fish oil, Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA)

Abstract

Major depressive disorder (MDD) is associated with long-chain omega-3 (LCn-3) fatty acid deficits and indices of chronic sustained inflammation including elevated C-reactive protein (CRP) levels. The present study combined a case-control analysis and a prospective 10-week open-label fish oil (FO) supplementation trial to investigate the relationships among plasma phospholipid LCn-3 fatty acid levels, plasma CRP concentrations, and depressive symptoms in adolescent MDD patients. Compared with healthy controls (n=20), MDD patients (n=20) exhibited significantly lower EPA+DHA levels (-62%, p£0.0001) and a higher ratio of arachidonic acid (AA) to EPA+DHA (+78%, p=0.0002). CRP concentrations did not differ between controls and MDD patients (0.16 vs. 0.17 mg/dL, p=0.96), and were positively correlated with depression symptom severity scores in MDD patients (r = +0.55, p=0.01). CRP concentrations were positively correlated with BMI in MDD patients (r = +0.63, p=0.005) and controls (r = +0.69, p=0.002). Low-dose (2.4 g/d) and high-dose (15 g/d) FO supplementation significantly increased EPA+DHA levels in MDD patients, but did not significantly alter CRP concentrations. Baseline and baseline-endpoint change in CRP levels were not correlated with baseline-endpoint reductions in depression severity. Together, these data demonstrate that the lower plasma phospholipid LCn-3 fatty acid composition exhibited by adolescent MDD patients is not associated with higher CRP levels, and that increasing LCn-3 fatty acid status reduces depression symptom severity independent of changes in CRP concentrations. Collectively, these data suggest that CRP concentrations are dissociable from LCn-3 fatty acid status and antidepressant response in adolescent MDD patients.

References

Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007; 22: 613-26. http://dx.doi.org/10.1002/gps.1723 DOI: https://doi.org/10.1002/gps.1723

Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167-81. http://dx.doi.org/10.1016/S0165-0327(01)00377-9 DOI: https://doi.org/10.1016/S0165-0327(01)00377-9

Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844-50. http://dx.doi.org/10.1001/archpsyc.58.9.844 DOI: https://doi.org/10.1001/archpsyc.58.9.844

McNamara RK. Membrane omega-3 fatty acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder. Cardiovasc Psychiatry Neurol 2009; 9: 1-13. http://dx.doi.org/10.1155/2009/362795 DOI: https://doi.org/10.1155/2009/362795

Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003; 65: 347-56. http://dx.doi.org/10.1097/01.PSY.0000041542.29808.01 DOI: https://doi.org/10.1097/01.PSY.0000041542.29808.01

Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004; 164: 1010-4. http://dx.doi.org/10.1001/archinte.164.9.1010 DOI: https://doi.org/10.1001/archinte.164.9.1010

Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171-86. http://dx.doi.org/10.1097/PSY.0b013e3181907c1b DOI: https://doi.org/10.1097/PSY.0b013e3181907c1b

Kling MA, Alesci S, Csako G, et al. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry 2007; 62: 309-13. http://dx.doi.org/10.1016/j.biopsych.2006.09.033 DOI: https://doi.org/10.1016/j.biopsych.2006.09.033

McNamara RK, Lotrich FE. Elevated immune-inflammatory signaling in mood disorders: A new therapeutic target? Expert Rev Neurother 2012; 12: 1143-61. http://dx.doi.org/10.1586/ern.12.98 DOI: https://doi.org/10.1586/ern.12.98

Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, et al. The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry 2006; 60: 825-30. http://dx.doi.org/10.1016/j.biopsych.2006.02.016 DOI: https://doi.org/10.1016/j.biopsych.2006.02.016

Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-9. http://dx.doi.org/10.1161/01.CIR.0000017493.03108.1C DOI: https://doi.org/10.1161/01.CIR.0000017493.03108.1C

Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41: 37S-42S. http://dx.doi.org/10.1016/S0735-1097(02)02953-4 DOI: https://doi.org/10.1016/S0735-1097(02)02953-4

Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204. http://dx.doi.org/10.1136/bmj.321.7255.199 DOI: https://doi.org/10.1136/bmj.321.7255.199

Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003; 100: 1751-6. http://dx.doi.org/10.1073/pnas.0334211100 DOI: https://doi.org/10.1073/pnas.0334211100

Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008; 79: 101-8. http://dx.doi.org/10.1016/j.plefa.2008.09.016 DOI: https://doi.org/10.1016/j.plefa.2008.09.016

Groeger AL, Cipollina C, Cole MP, et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 2010; 6: 433-41. http://dx.doi.org/10.1038/nchembio.367 DOI: https://doi.org/10.1038/nchembio.367

Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003; 278: 14677-87. http://dx.doi.org/10.1074/jbc.M300218200 DOI: https://doi.org/10.1074/jbc.M300218200

Reinders I, Virtanen JK, Brouwer IA, Tuomainen TP. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur J Clin Nutr 2012; 66: 736-41. http://dx.doi.org/10.1038/ejcn.2011.195 DOI: https://doi.org/10.1038/ejcn.2011.195

Murakami K, Sasaki S, Takahashi Y, et al. Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutr Res 2008; 28: 309-14. http://dx.doi.org/10.1016/j.nutres.2008.03.008 DOI: https://doi.org/10.1016/j.nutres.2008.03.008

Niu K, Hozawa A, Kuriyama S, et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006; 84: 223-9. DOI: https://doi.org/10.1093/ajcn/84.1.223

Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108: 155-60. http://dx.doi.org/10.1161/01.CIR.0000079224.46084.C2 DOI: https://doi.org/10.1161/01.CIR.0000079224.46084.C2

Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411: 584-91. http://dx.doi.org/10.1016/j.cca.2010.01.023 DOI: https://doi.org/10.1016/j.cca.2010.01.023

Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 1806-11. DOI: https://doi.org/10.1093/jn/134.7.1806

Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009; 205: 538-43. http://dx.doi.org/10.1016/j.atherosclerosis.2008.12.013 DOI: https://doi.org/10.1016/j.atherosclerosis.2008.12.013

McNamara RK, Rider T, Jandacek R, Tso P, Cole-Strauss A. Lipton JW. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 2010; 83: 185-91. http://dx.doi.org/10.1016/j.plefa.2010.08.004 DOI: https://doi.org/10.1016/j.plefa.2010.08.004

Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-55. http://dx.doi.org/10.1016/S0165-0327(97)00166-3 DOI: https://doi.org/10.1016/S0165-0327(97)00166-3

Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315-9. http://dx.doi.org/10.1016/S0006-3223(97)00206-0 DOI: https://doi.org/10.1016/S0006-3223(97)00206-0

Assies J, Pouwer F, Lok A, et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 2010; 5: e10635. http://dx.doi.org/10.1371/journal.pone.0010635 DOI: https://doi.org/10.1371/journal.pone.0010635

Riemer S, Maes M, Christophe A, Rief W. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord 2010; 123: 173-80. http://dx.doi.org/10.1016/j.jad.2009.08.004 DOI: https://doi.org/10.1016/j.jad.2009.08.004

Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68: 140-7. http://dx.doi.org/10.1016/j.biopsych.2010.03.018 DOI: https://doi.org/10.1016/j.biopsych.2010.03.018

McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord 2010; 126: 303-11. http://dx.doi.org/10.1016/j.jad.2010.03.015 DOI: https://doi.org/10.1016/j.jad.2010.03.015

Geller B, Zimerman B, Williams M et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 2001; 40: 450-5. http://dx.doi.org/10.1097/00004583-200104000-00014 DOI: https://doi.org/10.1097/00004583-200104000-00014

Poznanski EO, Cook SC, Carroll BJ, Corzo H. Use of the Children's Depression Rating Scale in an inpatient psychiatric population. J Clin Psychiatry 1983; 44:200-3.

Mayes TL, Bernstein IH, Haley CL, Kennard BD, Emslie GJ. Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents. J Child Adolesc Psychopharmacol 2010; 20: 513-6. http://dx.doi.org/10.1089/cap.2010.0063 DOI: https://doi.org/10.1089/cap.2010.0063

Lotrich FE, Sears B, McNamara RK. Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: Relationship with interleukin-6. Brain Behav Immun 2013; 31: 48-53. http://dx.doi.org/10.1016/j.bbi.2012.08.007 DOI: https://doi.org/10.1016/j.bbi.2012.08.007

Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8. http://dx.doi.org/10.1161/01.CIR.103.13.1813 DOI: https://doi.org/10.1161/01.CIR.103.13.1813

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-5. http://dx.doi.org/10.1001/jama.282.22.2131 DOI: https://doi.org/10.1001/jama.282.22.2131

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13. http://dx.doi.org/10.1542/peds.107.1.e13 DOI: https://doi.org/10.1542/peds.107.1.e13

Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170: 429-33. http://dx.doi.org/10.1007/s00213-003-1566-z DOI: https://doi.org/10.1007/s00213-003-1566-z

Chang HH, Lee IH, Gean PW, et al. Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun 2012; 26: 90-5. http://dx.doi.org/10.1016/j.bbi.2011.07.239 DOI: https://doi.org/10.1016/j.bbi.2011.07.239

Hamer M, Batty GD, Marmot MG, Singh-Manoux A, Kivimäki M. Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun 2011; 25: 168-73. http://dx.doi.org/10.1016/j.bbi.2010.09.013 DOI: https://doi.org/10.1016/j.bbi.2010.09.013

Schins A, Crijns HJ, Brummer RJ, et al. Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatr Scand 2007; 115: 35-40. http://dx.doi.org/10.1111/j.1600-0447.2006.00830.x DOI: https://doi.org/10.1111/j.1600-0447.2006.00830.x

Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003; 78: 40-6. DOI: https://doi.org/10.1093/ajcn/78.1.40

Geelen A, Brouwer IA, Schouten EG, Kluft C, Katan MB, Zock PL. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 2004; 58: 1440-2. http://dx.doi.org/10.1038/sj.ejcn.1601986 DOI: https://doi.org/10.1038/sj.ejcn.1601986

Madsen T, Christensen JH, Blom M, Schmidt EB. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 2003; 89: 517-22. http://dx.doi.org/10.1079/BJN2002815 DOI: https://doi.org/10.1079/BJN2002815

Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 2011; 93: 243-52. http://dx.doi.org/10.3945/ajcn.110.003871 DOI: https://doi.org/10.3945/ajcn.110.003871

Madsen T, Christensen JH, Schmidt EB. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Eur J Nutr 2007; 46: 428-30. http://dx.doi.org/10.1007/s00394-007-0673-8 DOI: https://doi.org/10.1007/s00394-007-0673-8

Meydani M, Natiello F, Goldin B, et al. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 1991; 121: 484-91. DOI: https://doi.org/10.1093/jn/121.4.484

Minoguchi K, Yokoe T, Tanaka A, et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 2006; 28: 378-85. http://dx.doi.org/10.1183/09031936.06.00084905 DOI: https://doi.org/10.1183/09031936.06.00084905

Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006; 163: 1098-100. http://dx.doi.org/10.1176/appi.ajp.163.6.1098 DOI: https://doi.org/10.1176/ajp.2006.163.6.1098

Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 2009; 63: 1037-40. http://dx.doi.org/10.1038/ejcn.2008.81 DOI: https://doi.org/10.1038/ejcn.2008.81

Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010; 91: 757-70. http://dx.doi.org/10.3945/ajcn.2009.28313 DOI: https://doi.org/10.3945/ajcn.2009.28313

Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 2012; 73: 81-6. http://dx.doi.org/10.4088/JCP.10r06710 DOI: https://doi.org/10.4088/JCP.10r06710

Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 2006; 67: 1954-1967. http://dx.doi.org/10.4088/JCP.v67n1217 DOI: https://doi.org/10.4088/JCP.v67n1217

Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68: 1056-61. http://dx.doi.org/10.4088/JCP.v68n0712 DOI: https://doi.org/10.4088/JCP.v68n0712

Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370-9. http://dx.doi.org/10.1016/S0893-133X(99)00134-7 DOI: https://doi.org/10.1016/S0893-133X(99)00134-7

Bot M, Carney RM, Freedland KE, et al. Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. J Psychosom Res 2011; 71: 13-7. http://dx.doi.org/10.1016/j.jpsychores.2010.11.006 DOI: https://doi.org/10.1016/j.jpsychores.2010.11.006

Downloads

Published

2013-12-30

How to Cite

McNamara, R. K., Perry, M., & Sears, B. (2013). Dissociation of C-Reactive Protein Levels from Long-Chain Omega-3 Fatty Acid Status and Antidepressant Response in Adolescents with Major Depressive Disorder: An Open-Label Dose-Ranging Trial. Journal of Nutritional Therapeutics, 2(4), 235–243. https://doi.org/10.6000/1929-5634.2013.02.04.8

Issue

Section

Articles